Jay H. Shubrook, DO

home / authors / jay-h-shubrook-do

Articles

October 27th 2015

Payer Source Influence on Effectiveness of Lifestyle Medicine Programs

Joseph Vogelgesang, BS David Drozek, DO Masato Nakazawa, PhD Jay H. Shubrook, DO

The health benefits for participants of the Complete Health Improvement Program ("CHIP"), a lifestyle medicine program, are present regardless of the program tuition payment source.

August 20th 2012

Racial Disparities in African Americans With Diabetes: Process and Outcome Mismatch

John B. Bulger, DO Jay H. Shubrook, DO Richard Snow, DO, MPH

Racial disparities are widespread in healthcare. Disparities can have a strong influence on diabetes care. This manuscript explores the source of such disparities.

Latest Updated Articles

Opdivo packaging | Image credit: Bristol Myers Squibb

Published: May 9th 2024 | Updated: May 21st 2024

FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors

AJMC Q&A with Dr Kristen Whitney | Background image credit: ipopba - stock.adobe.com

Published: August 28th 2024 | Updated: September 8th 2024

Illuminating the Future: Dr Kristen Whitney on What's Next for Dermoscopy

LDL and Lp(a) | Image credit : Amgen

Published: August 4th 2024 | Updated: September 8th 2024

Who Should Have Lp(a) Levels Tested? Experts Take Sides

ASCERTAIN Data: Oral Decitabine-Cedazuridine Outcomes in MDS

Published: September 3rd 2024 | Updated: September 8th 2024

ASCERTAIN Data: Oral Decitabine-Cedazuridine Outcomes in MDS

Luspatercept in Lower Risk MDS: Insights on the COMMANDS Trial

Published: September 3rd 2024 | Updated: September 8th 2024

Luspatercept in Lower Risk MDS: Insights on the COMMANDS Trial

Psoriasis | image credit: pimentos – stock.adobe.com.jpg

Published: August 28th 2024 | Updated: September 8th 2024

TYK2 Inhibitor Zasocitinib Shows High Efficacy, Safety in Moderate to Severe Psoriasis

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2024 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions